Mirati Therapeutics reported $-185727000 in EBITDA for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amgen AMGN:US USD 3.5B 62M
Astellas Pharma 4503:JP JPY 108.16B 38.67B
AstraZeneca AZN:LN USD 3.6B 404M
Bayer BAYN:GR EUR 2.45B 2.31B
Bluebird Bio BLUE:US USD -85093000 14.32M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Eisai 4523:JP JPY 7.71B 9.53B
Eli Lilly And LLY:US USD 2.31B 308.9M
Exelixis EXEL:US USD 88.28M 206K
Gilead Sciences GILD:US USD 3.28B 731M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
IONIS PHARMACEUT IONS:US USD -54729000 26.4M
Johnson & Johnson JNJ:US USD 7.81B 876M
Moderna Inc MRNA:US USD 1.28B 1.24B
Nektar Therapeutics NKTR:US USD -34794000 9.48M
Novartis NOVN:VX USD 4.69B 34M
Pfizer PFE:US USD 10.52B 2.78B
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
Seattle Genetics SGEN:US USD -175213000 59.32M
Takeda 4502:JP JPY 272.27B 36.53B
Ultragenyx Pharmaceutical RARE:US USD -220372000 83.26M
YTE INCY:US USD 134.94M 141.85M